It’s been a difficult year for the people of Guinea, Liberia and Sierra Leone, and all those fighting to end the terrible Ebola epidemic that took thousands of lives, spread fear and destabilized economies. Though the global response to this crisis was too slow, at year’s end, there are hopeful signs that international mobilization is having an impact, and that the countries most affected by the disease are coalescing around the goal of “zero cases.”
As we close the chapter on 2014, which is likely to be remembered in history as the “year of Ebola,” it is worth drawing some initial lessons for the future.
Today, the World Bank Group and the governments of Canada, Norway, and the United States announced that they will jumpstart the creation of an innovative Global Financing Facility to mobilize support for developing countries’ plans to accelerate progress on the health-related Millennium Development Goals and bring an end to preventable maternal and child deaths by 2030. Watch the video blog below for more on my thoughts about this exciting announcement.
A new World Bank Group analysis finds that if the Ebola epidemic continues to surge in Guinea, Liberia, and Sierra Leone, its economic impact could deal a catastrophic blow to the already fragile countries. However, swift national and international responses can limit the costs. Listen to World Bank Group President Jim Kim discuss the Ebola crisis and response in the video above, or read his latest post on LinkedIn.
This week’s links highlight the 500-day countdown to the MDG deadline, global response to #Ebola and the push towards universal health coverage. Each Friday, we share a selection of global health Tweets, infographics, blog posts, videos and more. Follow us @worldbankhealth.
This week's links include antimicrobial resistance, #AIDS2014 and information on Ebola via Vox. Each Friday, we share a selection of global health Tweets, infographics, blog posts, videos and more. Follow us @worldbankhealth.
Vaccination is one of the effective strategies to prevent FMD infection. Due to a high rate of mutation in FMD virus, there is an urgent need for the development of safe and effective vaccines for FMD.
“Bangladesh spends a lot of money to import FMD vaccines – but these are produced for foreign strains of FMD viruses, and they are ineffective against the virus strains circulating in Bangladesh. We need to have vaccine development capacity of our own,” says Prof. Anwar Hossain, Department of Microbiology of University of Dhaka and Manager of the sub-project titled, Foot and Mouth Disease in Bangladesh: Genome Analysis and Vaccine Development Project.
Prof. Anwar’s sub-project was awarded a competitive research grant of BDT 23.7 million (about US 304,000) from the Higher Education Quality Enhancement Project (HEQEP). His project is conducting studies to determine variation in FMD virus of Bangladesh origin and developing appropriate methods of prevention against FMD viruses. Using the fund, Prof. Anwar and his team upgraded their laboratory with essential modern scientific equipment such as real-time Polymerase Chain Reaction (PCR) machine to read DNA sequences and bio-safety cabinet together with a lot of indispensable laboratory consumables.
Since its inception in 2011, the sub-project has made significant achievements on their research work. These include completion of epidemiological study of serotype and lineage of FMD viruses, isolation and genome-wide analysis of FMD virus in Bangladesh, and publishing papers in international academic journals.